A cocktail of FDA-approved cancer drugs, trametinib and rapamycin, boosts the lifespan of lab mice by 30% and might help ...

Hepatocarcinoma is the most commonly diagnosed form of liver cancer. It is an aggressive, fast growing cancer with a 5-year ...

Discover four scientific-backed drinks that can significantly improve your liver health and overall well-being, including ...

The antibody PLT012 targets the fat transporter CD36 to restore immune responses in tumors, offering a new and promising ...

MASH can lead to cirrhosis and liver cancer. Only one drug has been approved ... Experiments in germ-free and specific pathogen–free mice tested colonization, safety, and metabolic outcomes ...

In a new study out this week, scientists report that a combination of two existing cancer drugs — rapamycin and trametinib — ...

Drug-induced liver injury (DILI) is a frequent cause of acute liver failure and drug withdrawals. Liver organoids, as a ...

Researchers from University College London and the Max Planck Institute for the Biology of Aging tested a combination of two ...

Scientists in Europe have tested an anti-aging drug cocktail in mice and found that it extended the animals' lifespans by ...

A study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy. A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal ...